港股詳情

本页面由TTMF Limited提供服务

劑泰科技-P待上市

10.500

0.000

成交量：- -

成交額：- -

市值：121.01億

市盈率：- -

高：10.500

開：10.500

低：10.500

收：10.500

52周最高：10.500

52周最低：10.500

股本：11.53億

香港流通股本：10.53億

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

市銷率: - -

1

开始申购

05/05

2

申購截止

05/08 10:15

3

公布中签

05/11

4

暗盘

05/12 16:15 - 18:30

5

挂牌上市

05/13

總覽公司新聞資訊公告

公司資料

公司名字：

劑泰科技-P

交易所：

SEHK

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.metistechbio.com/

郵編：

- -

電話：

- -

傳真：

- -

簡介：

AI納米遞送,開啟健康未來。劑泰科技是一家人工智能(AI)驅動納米材料創新的生物科技公司,專註於利用靶向藥物遞送和發現技術,加速患者在重要疾病領域獲得創新療法。公司由美國工程院院士陳紅敏博士以及MIT科學家賴才達博士、王文首博士聯合創立,成功自主開發了AI納米基座大模型及三大核心解決方案:AiLNP(AI納米遞送系統設計平台)、AiRNA(AI mRNA序列設計平台)、AiTEM(AI小分子製劑設計平台)。公司已具備實現肝臟、肺部、肌肉和免疫細胞等關鍵組織和細胞的LNP精準靶向遞送能力,在多器官、多組織靶向遞送難題上取得突破性進展,為腫瘤、代謝系統疾病、自體免疫性疾病、神經系統退行性疾病等提供成藥機會。

董事

名稱

職位

賴才達

董事會主席，執行董事，薪酬與考核委員會委員

Hongming Chen

執行董事，提名委員會委員

王文首

執行董事

林怡仲

獨立非執行董事，薪酬與考核委員會委員，審計委員會主席

李晉

獨立非執行董事，薪酬與考核委員會主席，提名委員會委員，審計委員會委員

Peter Edward Lobie

獨立非執行董事，提名委員會主席，審計委員會委員

黃瀚濤

非執行董事

公元

非執行董事

股東

名稱

職位

賴才達

首席執行官

付翀

首席財務官，董事會秘書，聯席公司秘書

王文首

首席運營官

李亮賢

聯席公司秘書

Mark Robert Herbert

首席商務官

徐偉

首席科學官

Hongming Chen

首席研發官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/07666/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07666","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"劑泰科技-P","latestPrice":10.5,"timestamp":1778054400000,"preClose":10.5,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":1052926111,"shares":1152513850,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"05-06 16:00:00","open":10.5,"high":10.5,"low":10.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1778635800000},"marketStatusCode":8,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":10.5,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":0,"ipoDetail":{"name":"剂泰科技－Ｐ","exchange":"SEHK","listingDate":"2026-05-13","sharesOutstanding":1152513850,"sharesFloat":1152513850,"offerAmount":201229000,"priceRange":"10.500","market":"HK","openProspectusDate":"2026-05-05","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500020_c.pdf","purchaseBeginDate":"2026-05-05","purchaseEndDate":"2026-05-08","winningDate":"2026-05-12","currency":"HKD","minPurchaseQuantity":500,"peRate":-27.94,"use":"1、约988.5百万港元（约50.0%）将用于支撑公司的人工智能基础设施及人工智能驱动纳米材料平台的核心技术研究、开发及推进；\n2、约395.4百万港元（约20.0%）将用于公司人工智能开发产品管线中正在进行及计划开展的临床试验；\n3、约197.7百万港元（约10.0%）将用于开发公司的动物健康及抗衰解决方案，并将人工智能赋能的解决方案拓展至该等高增长领域；\n4、约197.7百万港元（约10.0%）将分配用于支持公司在全球构建人工智能驱动纳米材料生态系统的增长战略；\n5、约197.7百万港元（约10.0%）将用作营运资金及其他一般企业用途。","industryId":"204005","industryName":"医疗保健","business":"公司是人工智能纳米材料创新的领军者，致力于有效载荷（Payload）在所有生命形态中的递送与应用，秉承以AI纳米创新开启健康未来。NanoForge是公司专有的、协同整合的人工智能驱动纳米科技创新体系的基础，涵盖公司自主生成的庞大脂质库、人工智能基础模型、METiS智能体、量子化学与分子动力学模拟及人工智能驱动的高通量筛选平台。在此基础上，公司开发了三大专业的解决方案（即AiTEM、AiLNP及AiRNA平台），用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","subscribed":513.9,"marketCap":12101000000,"minimumCapital":5302.95,"overAllotment":true,"lotSize":500,"issueOpenRate":0.05,"subscribeGear":"500,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,1000000,1500000,2000000,2500000,3000000,3500000,4000000,5030500","issueRatio":0.05,"offeringMechanism":"18C"},"greyMarketDetail":{"greyDate":"2026-05-12","greyDateTimestamp":1778515200000,"greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"showGreyQuote":false,"openProspectusDate":"2026-05-05","listingDate":"2026-05-13"},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","floatShares":1052926111,"roa":"--","roe":"--","lyrEps":0,"shares":1152513850,"dividePrice":0,"high":10.5,"amplitude":0,"preClose":10.5,"low":10.5,"week52Low":10.5,"pbRate":"--","week52High":10.5,"institutionHeld":0,"latestPrice":10.5,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":10.5},"@#url:\"https://hktrade.skytigris.com/ipos/general/07666\",,undefined,":{"id":9973,"type":"COMMON","ipoName":"07666-IPO","symbol":"07666","companyName":"劑泰科技-P","market":"HK","currency":"HKD","status":"OPEN","underwriter":"富瑞金融集團香港有限公司","lotSize":500,"minQty":500,"expectedOfferingSize":201229000,"openingDate":1777944600000,"closingDate":1778206500000,"commonClosingDate":1778206500000,"allotmentDate":1778428800000,"listDate":1778601600000,"marginable":true,"marginRate":10,"latestPrice":10.5,"minPrice":10.5,"maxPrice":10.5,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500020_c.pdf","allowedQuantities":[500,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,1000000,1500000,2000000,2500000,3000000,3500000,4000000,5030500],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1778169600000,"interestEndDate":1778342400000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1778573700000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"07666-IPO","ipoId":9973,"financingId":59540,"type":1,"availableFundLimit":5302.94,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":53029.4,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":5302.94,"threshold":50000000000,"isAvailable":false},{"ipoName":"07666-IPO","ipoId":9973,"financingId":59533,"type":4,"availableFundLimit":5302.94,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":5302.94,"threshold":50000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"FINANCING","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":5302.94},{"method":"CASH","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":5302.94}],"latestClosingDate":1778206500000,"subscribedFinanceRatio":513.9,"subscribedRatio":513.9,"forecastRatio":668.07,"raiseMoney":105650000,"totalMargin":54291520000,"quoteInfoUpdatedAt":1778101849049,"forecastMarketValue":12101395425,"minForecastMarketValue":12101395425,"maxForecastMarketValue":12101395425,"sharesOutstanding":1152513850,"business":"公司是人工智能納米材料創新的領軍者，致力於有效載荷（Payload）在所有生命形態中的遞送與應用，秉承以AI納米創新開啟健康未來。NanoForge是公司專有的、協同整合的人工智能驅動納米科技創新體系的基礎，涵蓋公司自主生成的龐大脂質庫、人工智能基礎模型、METiS智能體、量子化學與分子動力學模擬及人工智能驅動的高通量篩選平台。在此基礎上，公司開發了三大專業的解決方案（即AiTEM、AiLNP及AiRNA平台），用以模擬、預測及闡釋納米級別的相互作用關係，從而實現對先進納米材料及其相關有效載荷的合理設計、優化及驗證。","greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"tradable":true,"showClawback":true,"clawbackType":"18C 規則","clawbackRate":5},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.metistechbio.com/","compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0437},{"period":"3month","weight":-0.025},{"period":"6month","weight":-0.0011},{"period":"1year","weight":0.1567},{"period":"ytd","weight":0.0228}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"AI納米遞送,開啟健康未來。劑泰科技是一家人工智能(AI)驅動納米材料創新的生物科技公司,專註於利用靶向藥物遞送和發現技術,加速患者在重要疾病領域獲得創新療法。\n公司由美國工程院院士陳紅敏博士以及MIT科學家賴才達博士、王文首博士聯合創立,成功自主開發了AI納米基座大模型及三大核心解決方案:AiLNP(AI納米遞送系統設計平台)、AiRNA(AI mRNA序列設計平台)、AiTEM(AI小分子製劑設計平台)。\n公司已具備實現肝臟、肺部、肌肉和免疫細胞等關鍵組織和細胞的LNP精準靶向遞送能力,在多器官、多組織靶向遞送難題上取得突破性進展,為腫瘤、代謝系統疾病、自體免疫性疾病、神經系統退行性疾病等提供成藥機會。","exchange":"SEHK","name":"劑泰科技-P","nameEN":"METIS TECHBIO-P"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"07666\",market:\"HK\",,,undefined,":{"directors":[{"name":"賴才達","position":"董事會主席，執行董事，薪酬與考核委員會委員"},{"name":"Hongming Chen","position":"執行董事，提名委員會委員"},{"name":"王文首","position":"執行董事"},{"name":"林怡仲","position":"獨立非執行董事，薪酬與考核委員會委員，審計委員會主席"},{"name":"李晉","position":"獨立非執行董事，薪酬與考核委員會主席，提名委員會委員，審計委員會委員"},{"name":"Peter Edward Lobie","position":"獨立非執行董事，提名委員會主席，審計委員會委員"},{"name":"黃瀚濤","position":"非執行董事"},{"name":"公元","position":"非執行董事"}],"executives":[{"name":"賴才達","position":"首席執行官"},{"name":"付翀","position":"首席財務官，董事會秘書，聯席公司秘書"},{"name":"王文首","position":"首席運營官"},{"name":"李亮賢","position":"聯席公司秘書"},{"name":"Mark Robert Herbert","position":"首席商務官"},{"name":"徐偉","position":"首席科學官"},{"name":"Hongming Chen","position":"首席研發官"}]}}}